RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: Moderate Intensity Exercise for PTSD

The goal of this clinical trial is to test how exercise affects learning and memory processes relevant to the treatment of PTSD. Participants will complete a baseline intake followed by two experimental sessions.

Official registry: https://clinicaltrials.gov/study/NCT06127342 · Christal L Badour · enrollment listed as 100

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are Moderate Intensity Exercise, or Low Intensity Exercise. The registry lists allocation as randomized. The goal of this clinical trial is to test how exercise affects learning and memory processes relevant to the treatment of PTSD.

They plan to enroll about 100 people at 2 sites. Taking part typically means following a program (exercise, therapy, diet, or an app) plus check-ins.

Official title (unrewritten)

Exercise and Emotional Learning in Posttraumatic Stress Disorder

Interventions: Moderate Intensity Exercise, Low Intensity Exercise

Primary outcome (registry wording): Change in participant subjective emotional ratings

Who it is for (from inclusion criteria)

Ages 18 Years to 64 Years
Adults with PTSD related to interpersonal violence

Who the registry excludes

Active or recent (within the last 3 months) severe substance use disorder(s)
Active or recent (within the last 3 months) suicidal, psychotic, or manic symptoms/ episodes
Significant developmental disabilities
Current daily benzodiazepine or stimulant use with inability to abstain for study sessions
Recent changes in psychiatric medication or trauma focused cognitive-behavioral therapy (CBT) (past 4-weeks)
Medical condition(s) that prohibit exercise
History of traumatic brain injury (TBI) with loss of consciousness \> 30 mins

Public study contact (from the registry)

Christal G Badour, PhD

859-323-3817

christal.badour@uky.edu

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

2 listed

University of Kentucky — Lexington, Kentucky (recruiting)
University of Texas — Austin, Texas (recruiting)

Related recruiting trials in this snapshot

RecruitingNot a traditional drug phaseChicago, Illinois

Not a traditional drug phase: real iTBS for Mild Traumatic Brain Injury

This study will determine (i) the magnitude of immediate and sustained effects of a current clinical standard interactive computer attention processing training (APT) when combined with intermittent theta burst stimulation (iTBS), a type of repetitive transcranial magnetic stimulation and (ii) determine how APT + iTBS changes the neurocognitive system of attention in individuals with persistent attention deficits related to mTBI +/- PTSD.

NCT03819608 · Official ClinicalTrials.gov record · Northwestern University

RecruitingNot a traditional drug phaseLondon, Ontario

Not a traditional drug phase: Deep Brain Reorienting (DBR) for PTSD

This study will measure the how well it works of a therapeutic treatment, Deep Brain Reorienting (DBR), for PTSD (Post-traumatic Stress Disorder). you would be randomly assigned to either the DBR treatment, or wait-list condition.

NCT04317820 · Official ClinicalTrials.gov record · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

RecruitingNot a traditional drug phaseRichmond, Virginia

Not a traditional drug phase: Antioxidant for Peripheral Vascular Diseases

The purpose of this research study is to examine the role oxidants, substances produced in the blood that can damage blood vessel function, may play in blood vessel function in healthy individuals as well as individuals with mental health disorders (posttraumatic stress disorder (PTSD) and/or generalized anxiety disorder (GAD)).

NCT04916327 · Official ClinicalTrials.gov record · Virginia Commonwealth University

FAQ about this NCT record

Is NCT06127342 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT06127342?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT06127342?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary